Healthcare Global Enterprises — 360° view

Healthcare Global Enterprises, a company in the Hospital industry, reported revenue of ₹732 crore and net profit of ₹9.25 crore for the September 2026 quarter.

Healthcare Global Enterprises (NSE: HCG) closed at ₹624.95 on 20 Nov 2026, down 15.4% over the past year. Its market capitalisation is ₹9,331 crore and it trades at 235.0 times earnings.

Share price
₹624.95 (20 Nov 2026)
Market cap
₹9,331 Cr (20 Nov 2026)
P/E
235.01 (20 Nov 2026)
Revenue
₹732 Cr (September 2026 quarter)
Net profit
₹9 Cr (September 2026 quarter)
ROCE
8.30% (FY26)
ROE
2.54% (FY26)
Book value
₹90.3 (FY26)
Dividend yield
0.00% (last 12 months to 20 Nov 2026)
52-week high / low
₹775.00 / ₹513.30 (20 Nov 2026)
1-year return
-15.4% (to 20 Nov 2026)
Sector
Healthcare
Industry
Hospital
Symbol
NSE: HCG

Healthcare Global Enterprises Ltd is engaged in setting up and managing hospitals and medical diagnostic services including scientific testing and consultancy services in the pharmaceutical and medical sector.

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.